Patent details

EP1007094 Title: Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying

Basic Information

Publication number:
EP1007094
PCT Application Number:
PCT/SE/97/02068
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP979505427
PCT Publication Number:
WO/98/28009
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying
French Title of Invention:
Compositions pharmaceutiques comprenant un analogue d'un nucléotide destinées à la lyophilisation
German Title of Invention:
Pharmazeutische Zusammensetzungen enthaltend ein Nucleotid Analog, geeignet für Gefriertrocknung
SPC Number:

Dates

Filing date:
11/12/1997
Grant date:
07/08/2002
EP Publication Date:
07/08/2002
PCT Publication Date:
02/07/1998
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2000
EP B1 Publication Date:
07/08/2002
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/12/2017
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/12/1997
 
 

Name:
AstraZeneca UK Limited
Address:
15 Stanhope Gate, London W1Y 6LN, United Kingdom (GB)

Agent

Name:
WAXWEILER Jean
From:
31/10/2002
Address:
PO Box 1502, 1015, Luxembourg, Luxembourg (LU)
To:

Inventor

1

Name:
STEELE Gerald
Address:
United Kingdom (GB)

2

Name:
BLAND Chris
Address:
United Kingdom (GB)

Priority

Priority Number:
9604795
Priority Date:
20/12/1996
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 47/26;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/11/2016
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages